Elevating Wellness: Janey Secures $3000 to Fuel a New Era of Cannabis-Health Balance

We’re excited to announce that Janey has raised $3,000 in its latest funding round—a major milestone that reinforces our commitment to developing high-quality health and wellness supplements at the intersection of health and high. At Janey, our passion lies in creating scientifically backed products designed to support the well-being of our customers, especially those navigating the unique challenges of modern lifestyles. Our flagship supplement, also named Janey, specifically targets the cardiovascular inflammation associated with D9-THC, the psychoactive compound found in cannabis. By addressing this critical aspect of health, we empower our users to maintain a balanced state of well-being, even as they explore the benefits of cannabis responsibly. This new capital injection will play a pivotal role in further advancing our research and development efforts, ensuring our products are not only effective but also safe and accessible. The funds will be dedicated to enhancing our production capabilities, expanding our educational initiatives, and deepening our engagement with a community keen to understand the broader implications of their health choices. We believe in the transformative power of merging innovation with education, and this investment is a testament to our mission of equipping our customers with both superior products and vital health insights. As we celebrate this moment, we extend our heartfelt gratitude to our investors and supporters whose trust in our vision fuels our journey. Join us as we continue to explore new horizons in wellness and strive to offer products that truly balance the best of both worlds—health and high.